Harvard Health Blog

Sleep drug dosage change aims to avoid daytime drowsiness

Posted January 16, 2013, 1:05 pm Daniel Pendick, Former Executive Editor, Harvard Men's Health Watch Last week, the FDA urged doctors to lower the starting dose of zolpidem, a popular prescription sleep aid, due to concerns that the drug can linger too long in the body. This causes daytime drowsiness that has led to car accidents. Sleep aids affected by the FDAs announcement includes generic zolpidem and brand names Ambien, Ambien CR, Edluar,…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In